Leaderboard

En | De
Sie sind hier: Neurologie » Alzheimer 10. Juli 2026
Suchen
medline.ch
Alzheimer
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Alzheimer
Epilepsie
Infektionen
Kopfschmerzen
Multiple Sklerose
Neoplasie
Neuromuskuläre Erkrankungen
Parkinson
Zerebrovaskuläre Erkrankungen
ZNS Trauma
Anderes
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 3565  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 71300  
   
Retinal Transcriptome-Wide Association Study Identifies Novel Alzheimer's Disease Risk Genes.
medRxiv
Zhang Y, Chen B, Sun H, Shi R, Li Y, Du J, Horimoto ARVR.
PMID: 42428058 [PubMed - in process]


Diagnosis of Alzheimer's disease from neuroimages using steerable quantum probabilistic hamiltonian generative modeling with adaptive chaotic satin bowerbird optimization.
Cogn Neurodyn
Aggarwal K, Ramu V, Padmanaban K, Hemalatha B.
PMID: 42428045 [PubMed - in process]


FuzzyFed-CNN: secure and explainable multimodal federated learning for early Alzheimer's diagnosis.
Front Artif Intell
Mohanraj S, Radhakrishnan S.
PMID: 42428004 [PubMed - in process]


Safety considerations of gene-based therapies for Alzheimer's disease.
Alzheimers Dement
Bevins EA, Léger GC, Herman MA, Ringman JM, Roy S, Shtrahman M, Pa J, Feldman HH.
PMID: 42427159 [PubMed - in process]


Diagnostic delay in early-onset Alzheimer's disease in Japan: a retrospective study.
BMC Neurol
Kasuga K, Shimizu S, Kimura N, Kasanuki K, Sakurai S, Serisawa S, Masuda T, Ataka T, Tadokoro M, Hashimoto C, Shiina H, Nakamura Y.
PMID: 42426644 [PubMed - as supplied by publisher]


Targeting the Pathological Tau N368 Fragment: A Pharmacological Perspective on a Novel Immunotherapy for Alzheimer's Disease.
Pharmacol Res
Qian Z, Hu Z, Li Y, Zuo D, He R, Ye K.
PMID: 42425476 [PubMed - as supplied by publisher]


Longifolene mitigates amyloid beta induced neurotoxicity by acting on PI3K/AKT/NFκB pathway: Comprehensive in vitro, in vivo pharmacokinetics and pharmacodynamic studies for Alzheimer's disease.
Eur J Pharmacol
Thakkar A, Mote C, Gadade A, Dighe V, Kaur G, Vora A.
PMID: 42425385 [PubMed - as supplied by publisher]


Synaptic Dysfunction as a Major Driver in Alzheimer's Disease: Beyond the Amyloid Paradigm.
Neurosci Biobehav Rev
Mierzwa N, W.
PMID: 42425281 [PubMed - as supplied by publisher]


Recent advances in Alzheimer's disease: From molecular mechanisms to therapeutic strategies.
Cell
Rudman MD, Ulrich JD, Holtzman DM.
PMID: 42425064 [PubMed - in process]


The heat exposure, aging trajectories, and Alzheimer's disease (HEAT-AD) study protocol.
PLoS One
O'Shea DM, Chang LC, Chowdhury M, Cook DJ, Cresswell K, Minor BD, Mitsova D, Tourelle MS, Galvin JE, Besser LM.
PMID: 42424329 [PubMed - indexed for MEDLINE]


Metabolic risk and metabolic dysfunction-associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study.
PLoS One
Nasir AB, Kilani Y, Aldiabat M, Abdelghany O, Hafez Y, Desai N, Madi MY, Wade FG, Qureshi K, Frey LJ, Farmer AD, Syn WK.
PMID: 42424274 [PubMed - indexed for MEDLINE]


Autophagy in Alzheimer's disease: mechanisms, clinical trials, and horizons.
Neurodegener Dis
Tshimbombu TN, Thurmann KE, Decourt B, Nyalundja AD, Shardow SB, Amoako ME, Iragi GM, Mwambali JA, Sabbagh MN.
PMID: 42424238 [PubMed - as supplied by publisher]


Alzheimer Disease Biomarkers and Assisted Dying: When Diagnosis Becomes a Deadline.
JAMA
Lyndon S, Behlke LM, Urizar JC, Daffner KR.
PMID: 42424076 [PubMed - as supplied by publisher]


A real-world decision tree model based on ¹â¸F-FDG PET/CT Z scores and Mini-Mental State Examination for differentiating mild cognitive impairment from clinically diagnosed Alzheimer disease.
Ann Nucl Med
Övüt AR, Toyran R, Bülbül NG, Urhan M.
PMID: 42423959 [PubMed - as supplied by publisher]


A nose-to-brain drug delivery system targeting mitochondrial dysfunction: application potential and future prospects of chitosan nanogels in Alzheimer's disease.
Biomater Sci
Huang Q, Zuo Y, Xie Y, Liu Z, Wang L, Xu H, Yu M, Liu C.
PMID: 42423667 [PubMed - as supplied by publisher]


Frailty as an underrepresented dimension in clinical trials of Alzheimer's disease therapies.
J Alzheimers Dis
Solfrizzi V, Imbimbo BP.
PMID: 42423483 [PubMed - as supplied by publisher]


Efficacy, safety and policy implications of anti-amyloid monoclonal antibodies for Alzheimer's disease: protocol for a living systematic review and meta-analysis.
BJPsych Open
Kim S, Oda H, Oyama R, Makishi R, Bade S, Bade S, Ally I, Iijima Y, Gibo Y, Minami K, Fukuzawa F, Sanji S, Inamine K, Kishi H, Huh S, Tanifuji T, Nagahiro M, Watanabe N.
PMID: 42423023 [PubMed]


Clinical, Radiological, and Immunohistological Distinctions Between Limbic-Predominant and Typical Alzheimer's Disease: A Systematic Review.
Brain Behav
Secco GL, Qureshi K, Shafeea MS, Karpinski PH, Wouters K, Merlim da Silva MC, Ganta SR, von Quednow E, Guzmán-Ríos ED, Brice KS, Dsouza M, Fernandes A Junior, Noori NN, Chaurasia B, Yangi K.
PMID: 42422911 [PubMed - indexed for MEDLINE]


Osteoimmuno-brain axis: a bridge connecting osteoporosis and cognitive decline and its clinical significance in dementia and Alzheimer's disease.
Front Immunol
Xu G, Cheng Z, Zhou Y, Guo L, Zhu H, Shen Z.
PMID: 42421969 [PubMed - indexed for MEDLINE]


Could the cognitive benefits of amyloid-beta clearance grow in time for Alzheimer's disease?
Transl Psychiatry
He CY, Wang XY, Fan J, Wang YN, Masters CL, Wang YJ.
PMID: 42420256 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 71300    Seite 1 von 3565  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1